Долгая жизнь с муковисцидозом. Коллектив авторов. Читать онлайн. Newlib. NEWLIB.NET

Автор: Коллектив авторов
Издательство: Автор
Серия:
Жанр произведения: Здоровье
Год издания: 2015
isbn: 978-5-4461-0329-4
Скачать книгу
2008; 31: 1789-94.

      320

      Marshall ВС, Butler SM, Stoddard M, et al. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005; 146: 681-7.

      321

      KochC, RainisioM, Madessani U, et al. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001; 32: 343-50.

      322

      Moran A, Doherty L, Wang X, et al. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998; 133: 10–17.

      323

      Huang CJ, Lin CY, Haataja L, et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 2007; 56: 2016-27

      324

      Minicucci L, Cotellessa M, Pittaluga L, et al. Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis. J Pediatr Endocrinol Metab 2005; 18: 755-60.

      325

      Lanng S, Thorsteinsson B, Pociot F, et al. Diabetes mellitus in cystic fibrosis: genetic and immunological markers. Acta Paediatr 1993; 82: 150-4.

      326

      Lombardo F, De Luca F, Rosano M, et al. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol 2003; 149: 5

Примечания

1

Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am J Dis Child 1938; 56: 344-9

2

Cystic Fibrosis Trust. Annual data report 2010. Bromley: Cystic Fibrosis Trust; 2011. Available from: https://www.cysticfibrosis.org.uk/media/108230/CR_Annual_Data_ Report_20_Dec_11.pdf

3

Warwick WJ, Pogue RE, Gerber HU, et al. Survival patterns in cystic fibrosis. J Chronic Dis 1975; 28: 609-22.

4

Cystic Fibrosis Trust. Annual data report 2010. Bromley: Cystic Fibrosis Trust; 2011. Available from: https://www.cysticfibrosis.org.uk/media/108230/CR_Annual_Data_ Report_20_Dec_11.pdf

5

Cystic Fibrosis Trust. Annual data report 2012. Bromley: Cystic Fibrosis Trust; 2013. Available from: https://www.cysticfibrosis.org.uk/media/316760/Scientific%20 Registry%20Review%20 2012.pdf

6

Cystic Fibrosis Foundation Patient Registry. 2012 Annual Data Report. Bethesda, Maryland; 2013. Available from: www.cff.org/UploadedFiles/research/Clinical Research/PatientRegistryReport/2012-CFF-Patient-Registry.pdf

7

Cystic Fibrosis Foundation Patient Registry. 2012 Annual Data Report. Bethesda, Maryland; 2013. Available from: www.cff.org/UploadedFiles/research/Clinical Research/PatientRegistryReport/2012-CFF-Patient-Registry.pdf

8

Zolin A, McKone EF, Van Rens J, et al. European Cystic Fibrosis Society Patient Registry Annual Data Report 2010. Karup: ECFS; 2014. Available from: https:// www.ecfs.eu/files/webfm/web-files/File/ecfs_registry/ECFSPR_ Report10_v12014_final_020617. pdf

9

Zolin A, McKone EF, Van Rens J, et al. European Cystic Fibrosis Society Patient Registry Annual Data Report 2010. Karup: ECFS; 2014. Available from: https:// www.ecfs.eu/files/webfm/web-files/File/ecfs_registry/ECFSPR_ Report10_v12014_final_020617. pdf

10

McCormick J, Mehta G, Olesen HV, et al. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet 2010; 375: 1007-13.

11

Dodge JA, Lewis PA, Stanton M, et al. Cystic fibrosis mortality and survival in the UK: 1947–2003. Eur Respir J 2007; 29: 522-6.

12

di Sant'Agnese PA, Darling RC, Perera GA, et al. Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease. Pediatrics 1953; 12:549-63.

13

Riordan JR, RommensJM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245:1066-73.

14

RommensJM, lannuzzi MC, Kerem B, et al. Identification of the cystic fibrosis gene: chromosome

15

Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970–1989. Am J Epidemiol 1996; 143: 1007-17.

16

Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984; 104: 206-10.

17

Milla CE, Billings J, Moran A. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005; 28: 2141-4.

18

Chotirmall SH, Smith SG, Gunaratnam C, et al. Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis. N Engl J Med 2012; 366:1978-86.

19

Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011; 365: 1663-72.

20

Saiman L, Marshall ВС, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003; 290: 1749-56.

21

Fuchs FIJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994; 331: 637-42.

22

Pryor J, Tannenbaum E, Scott S, et al. Beyond postural drainage and percussion: airway clearance in people with cystic fibrosis. J Cyst Fibros 2010; 9: 187-92.

23

Mahadeva R, Webb K, Westerbeek RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998; 316: 1771-5.

24

Hamosh A, Rosenstein B, Nash E, et al. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med 1993; 329: 1308-13.

25

McKone EF, Emerson SS, Edwards KL, et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003; 361: 1671-6.

26

McCloskey M, Redmond A, Hill A, et al. Clinical features associated with a delayed diagnosis of cystic fibrosis. Respiration 2000; 67: 402-7.

27

NickJA, Rodman DM. Manifestations of cystic fibrosis diagnosed in adulthood. Curr Opin Pulm Med 2005; 11:513-18.

28

Augarten A, Yahav Y, Szeinberg A, et al. Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849+ 10 kb C→T mutation. Lancet 1993; 342: 25–6.

29

McKone EF, Emerson SS, Edwards KL, et al. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003; 361: 1671-6.

30

Schechter MS. Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions. Semin Respir Crit Care Med 2003; 24: 639-52.

31

BlackmanS, HsuS, RitterS, etal. A susceptibility gene for type 2 diabetes confers substantial risk for diabetes complicating cystic fibrosis. Diabetologia 2009; 52: 1858-65.

32

Bartlett JR, Friedman KJ, Ling SC, et al. Genetic modifiers of liver disease in cystic fibrosis. JAMA 2009; 302: 1076-83.